Haleon plc (HLNCF)
| Market Cap | 43.12B |
| Revenue (ttm) | 15.07B |
| Net Income (ttm) | 1.62B |
| Shares Out | n/a |
| EPS (ttm) | 0.18 |
| PE Ratio | 26.63 |
| Forward PE | n/a |
| Dividend | 0.03 (0.54%) |
| Ex-Dividend Date | Aug 15, 2024 |
| Volume | 3,199 |
| Open | 4.700 |
| Previous Close | 4.780 |
| Day's Range | 4.700 - 4.910 |
| 52-Week Range | 3.900 - 5.360 |
| Beta | 0.19 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 27, 2025 |
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops,... [Read more]
Full Company ProfileFinancial Performance
In 2023, Haleon's revenue was 11.30 billion, an increase of 4.09% compared to the previous year's 10.86 billion. Earnings were 1.05 billion, a decrease of -1.04%.
Financial numbers in GBP Financial StatementsNews
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?
Pfizer Inc. (NYSE: PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance . Ahead of the call, Goldman Sachs has outlined its expectations for the guide and commen...
Haleon Pakistan to manufacture Centrum multivitamins
Haleon Pakistan plans to start manufacturing multivitamin brand Centrum in the country for domestic sales and export, its CEO said, as it seeks to boost sales in the country amid lower inflation.
Haleon: Guidance Implies Uncertainty Around Flu Season
Leading Consumer Health Transformation With Purpose at Haleon
In this compelling episode of the Brave Commerce podcast, co-hosts Rachel Tipograph and Sarah Hofstetter sit down with Katie Williams, chief marketing officer of Haleon, parent company of consumer hea...
Haleon Welcomes Joe Sta-Romana as Chief Customer Officer to Lead US Growth and Transformation
WARREN, N.J. , Dec. 2, 2024 /PRNewswire/ -- Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its US busines...
Haleon Partners with WPP to Launch ‘HealthNxt’ initiative to Transform Health Conversations in India
Through the commitment of #HealthInMoreHands, Haleon aims to democratize healthcare in India, empowering individuals to take control of their health. NEW DELHI, Nov. 20, 2024 /PRNewswire/ — Haleon (fo...
Dividend Income: Lanny's October 2024 Summary
Big Oil with BHP Billiton came big with a massive dividend. Canadian Imperial, one of the big 6 Canadian banks, sent a massive $210 dividend my way. There are a few less names now in 2024 than 2023, s...
Eminence Capital buys Gitlab, Charles River, exits Haleon, others in Q3
Eminence Capital added new positions in Gitlab, Charles River, Okta, and Atmus Filtration while exiting stakes in Haleon, Wix.com, Prologis, and GoDaddy in...
Haleon Selects Vistar Media as Preferred Global Partner for Programmatic Out-of-Home (OOH) Advertising
Vistar Media's programmatic OOH technology to enhance Haleon's premium, global media strategy Vistar Media's programmatic OOH technology to enhance Haleon's premium, global media strategy
Haleon plc (HLN) Q3 2024 Sales Call Transcript
Haleon CEO Brian McNamara: We've seen double-digit growth in China
Haleon CEO Brian McNamara joins 'Mad Money' host Jim Cramer to talk quarterly results, China growth, consumer trends and more.
Revenues fall at Sensodyne maker Haleon after weaker painkiller sales
Shares were lower in early trading on Thursday as a result.
Haleon reports marginal decline in third-quarter revenue
Haleon reported a marginal fall in its third-quarter revenue on Thursday, hurt by declines in its pain relief and digestive health segments.
Is the Haleon share price in trouble ahead of earnings?
Haleon (HLN) share price has retreated in the past few weeks, erasing some of the gains made earlier this year. Its London stock dropped to 375p, its lowest point since August 29, while its American A...
Haleon: Too Vanilla For My Liking - I See Why GSK & Pfizer Wanted Out
Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock and why I recommend a sell rating.
Haleon: Tailwinds Are Mostly Priced In
Tombras Acquires New York Agency The Burns Group
Global independent agency Tombras has acquired The Burns Group, an independent advertising agency based in New York. The acquisition further bolsters Tombras' capabilities with top CPG clients, includ...
Pfizer sells further shares in Sensodyne maker Haleon for £2.4bn
Haleon was formed in 2019 by the merger of the consumer healthcare businesses of GSK and US rival Pfizer, but was spun out and floated in 2022.
Pfizer cuts Haleon stake in $3.3B share sale
Pfizer (PFE) reduces its stake in Haleon to 15% from 22.6% by selling £2.45B worth of shares, continuing its gradual divestment strategy. Read more here.
Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
Pfizer Inc. (NYSE: PFE) has divested a $3.3 billion stake in Haleon (NYSE: HLN), reducing its holding in the British consumer healthcare company. What Happened : The transaction occurred on Monday, ...
Pfizer offloads $3.3 bln stake in Sensodyne-maker Haleon
Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said on Tuesday.
Dr Reddy's completes acquisition of UK co Haleon's non-US nicotine replacement therapy biz
Hyderabad-based pharma giant Dr Reddy’s Ltd finalizes its largest acquisition by buying British Haleon Plc’s non-US nicotine replacement therapy (NRT) business for GBP 458 million. The deal includes b...
Pfizer to Pare Back Haleon Stake With 540 Million Share Offering
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health giant.
Pfizer to offload about 5.9% stake in UK's Haleon, says bookrunner
Pfizer intends to offload about 540 million shares in the British consumer healthcare company Haleon , a bookrunner said on Monday.
Sensodyne maker Haleon to raise stake in China JV
British consumer healthcare company Haleon said on Friday it has agreed to raise its stake in its Chinese joint venture by 33% for 4.47 billion yuan ($637.35 million), taking its ownership to 88%.